Identification of an immune-related gene signature for predicting prognosis and immunotherapy efficacy in liver cancer via cell-cell communication

Figure 5 Box plots depicting the expression analysis of the genes employed in constructing the gene signature. A-C: Expression analysis of C-C chemokine ligand 5 (CCL5), cofilin 1 (CFL1), and stathmin 1 (STMN1) in the high-risk and low-risk groups; D-F: Expression analysis of CCL5, CFL1, and STMN1 in the tumor and normal groups. The high-risk and normal groups are represented by red boxes, while the low-risk and tumor groups are represented by blue boxes. The significant differences between groups were evaluated through t tests. CCL5: C-C chemokine ligand 5; CFL1: Cofilin 1; STMN1: Stathmin 1.